California Cancer Reporting System Standards, Volume III
CoC
California Hospital Transmit
Eureka Admission Level
Eureka Tumor Level
TNM Clin N [NAACCR #950]
CS Site-Specific Factor 1 [NAACCR #2880]
CS Site-Specific Factor 2 [NAACCR #2890]
Date of Diagnosis [NAACCR #390]
Primary Site [NAACCR #400]
Histologic Type ICD-O-3 [NAACCR #522]
Age at Diagnosis [NAACCR #230]
CS Site-Specific Factor 10 [NAACCR #2864]
CS Site-Specific Factor 25 [NAACCR #2879]
Grade [NAACCR #440]
Sex [NAACCR #220]
Type of Reporting Source [NAACCR# 500]
Behavior Code ICD-O-3 [NAACCR# 523]
N/A
IF1176: TNM Clin N [value] and CS Site-Specific Factor 1 [value] conflict
IF1176: TNM Clin N [value] and CS Site-Specific Factor 2 [value] conflict
The edit verifies consistency between the CS Site-Specific Factor coding Clinical Assessment of Lymph Nodes, and the assigned TNM Clin N category.
This edit is skipped if any of the following conditions are true:
Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid
Type of Reporting Source = 7 (Death Certificate Only)
Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
Site/Histology group is not included in list below (not 10A,10B,011,012,13A,13B,014,17A,17C)
TNM Clin N is blank or 88
SSF coding nodes assessment is blank or 988
TNM Edition Number not = 07, U7
(Site/histology group is determined before skips 4 and 6 are applied.)
TNM Clin N may be blank. If entered, it will be edited site-specifically. Code 400, clinically positive regional node(s), NOS, will be accepted with any TNM Clin N value except cN0 for site/histology groups 10A,10B,11,12,13A,13B, and 14.
The site-specific TNM Clinical N values with the corresponding codes in the Site-Specific Factor used to collect the information are listed below. The number next to each site title indicates the respective chapter in the AJCC Cancer Staging Manual, Edition 7. The list includes only those digestive site/histology groups where assessment of clinical N is coded separately in a site-specific factor.
The site/histology groups are identified by site and histology in the edit Primary Site, Stage Group 2016 - Ed 7.
Esophagus and Esophagus Gastric Junction
10A. Esophagus
10B. Esophagus Gastric Junction
TNM N Clin |
X |
0 |
1 |
2 |
3 |
SSF 1 |
999,400 |
000 |
100,400 |
200,400 |
300,400 |
Stomach
TNM N Clin |
X |
0 |
1 |
2 |
3 |
3A |
3B |
SSF 1 |
999,400 |
000 |
100,400 |
200,400 |
300,400 |
310,400 |
320,400 |
Small Intestine
TNM N Clin |
X |
0 |
1 |
2 |
SSF 1 |
999,400 |
000 |
100,400 |
200,400 |
Appendix
13A. Appendix: Carcinoma
TNM N Clin |
X |
0 |
1 |
2 |
SSF 1 |
999,400 |
000 |
100,400 |
200,400 |
13B. Appendix: Carcinoid
TNM N Clin |
X |
0 |
1 |
SSF 1 |
999,400 |
000 |
100,200,400 |
Colon and Rectum
TNM N Clin |
X |
0 |
1 |
1A |
1B |
2 |
2A |
2B |
SSF 1 |
999,400 |
000 |
100,400 |
010,400 |
020,400 |
200,400 |
110,400 |
120,400 |
Neuroendocrine Tumors (NET)
17A. NET: Stomach
TNM N Clin |
X |
0 |
1 |
SSF 1 |
999 |
000 |
100, 200, 300, 400 |
17C. NET: Colon and Rectum
TNM N Clin |
X |
0 |
1 |
SSF 1 |
999 |
000 |
100, 200, 400 |
In the SEER*Edits software, the title of this edit is: IF600. |
|
08/2016 |
Per NAACCR v16, new edit added. |
11/2016 |
Per NAACCR v16B, corrected edit logic for assigning site/histology group 011 to group 10B or 999 based on histology and CS Site-Specific Factor 25. |
11/2016 |
Per NAACCR v16C, description, edit logic modified to not fail when TNM Clin C = cX and CS SSF 1 or 2 = 400 for site/histology groups 10A,10B,11,12,13A,13B, and 14. If number of nodes involved is unknown and number is required to assign TNM Clin N, TNM Clin N = cX is appropriate. |
03/2017 |
Per NAACCR v16D:
|